Enarodustat for anemia in chronic kidney disease (not on dialysis)
Treatments studied
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 75 years old
- Weigh between 99 and 220 pounds (45 to 100 kg)
- Have chronic kidney disease stages 2 to 5 and not on dialysis
- Have anemia (low red blood cells) linked to kidney disease, with specific hemoglobin levels
- Have enough iron in your body (ferritin over 100 μg/L or transferrin saturation over 20%)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a daily pill that helps people with chronic kidney disease and anemia make more red blood cells, which may reduce the need for other anemia treatments. It is for patients who are not on dialysis and do not plan to start dialysis or have a kidney transplant within the next six months.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This study tests different starting doses of a pill called enarodustat to see which works best for anemia in people with chronic kidney disease who are not on dialysis. It aims to help raise red blood cell counts and reduce the need for injections.
This trial tests an oral medication (AND017) for anemia caused by chronic kidney disease. It aims to improve red blood cell levels without needing dialysis or current anemia treatments.
This trial tests whether a new drug called enarodustat, when combined with cyclosporine, can improve blood cell counts better than cyclosporine alone in people with transfusion-dependent non-severe aplastic anemia. If you qualify, you might need fewer transfusions and feel better overall.
This study compares two anemia medicines for people with chronic kidney disease (CKD) who are not on dialysis. It aims to find a more convenient pill option (daprodustat) versus a commonly used injection (epoetin alfa).
Hear when a new Chronic Kidney Disease Associated Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.